ABC transporters of Fasciola hepatica as putative drug targets by El-Kasaby, Ali et al.
MEETING ABSTRACT Open Access
ABC transporters of Fasciola hepatica as putative
drug targets
Ali El-Kasaby, Thomas Stockner, Oliver Kudlacek
*
From 17th Scientific Symposium of the Austrian Pharmacological Society (APHAR). Joint meeting with the
Hungarian Society of Experimental and Clinical Pharmacology (MFT)
Innsbruck, Austria. 29-30 September 2011
Background
The liver fluke Fasciola hepatica is one of the most
important parasites affecting animal health all over the
world, causing the so called liver fluke disease (fasciolio-
sis). Although infections of humans are rather rare in
most western countries, several million people worldwide
are infected by this trematode. Beside its threat to
humans the infection of animal stock leads to large finan-
cial losses. As vaccinations against this parasite are not
available yet, anthelmintic drugs, like triclabendazole, are
the treatment of choice. During the last decades more
and more flukes resistant to these drugs have been
found. One possible mechanism for these resistances
seems to be the expression of so called ABC transporters.
Inhibitors of P-glycoprotein (ABCB1) can change the
status of flukes from resistant to susceptible. Up to date
little is known about proteins expressed by the fluke. In
addition almost no information on the fluke’sg e n o m ei s
available. We therefore try to identify and characterize
yet unknown proteins of the fluke to investigate their
potentency as putative new drug targets.
Methods
Starting from a previously published sequence of an
ABC transporter of Fasciola hepatica we used RACE
(rapid amplification of cDNA ends) to generate a full
length ABC transporter. Heterologous expression of the
protein allows basic analysis of this transporter. Other
proteins will be identified by screening a cDNA library,
prepared from flukes isolated from the liver of infected
cows.
Results and conclusions
Comparison of the published sequence of a previously
identified ABC transporter from Fasciola hepatica with
other transporters of this family revealed that the sequence
was lacking the first six transmembrane regions of the
transporter. After cloning of the missing part, it became
clear that this transporter is highly homolgous not only to
ABC transporters of the evolutionary close Schistosoma
mansonii, but also to transporters of mammals. Expression
of this transporter in eukaryotic cell lines should therefore
allow testing the transporter’s properties, identifying sub-
strates and blockers, and therefore getting a glance on
future approaches that can be used to treat fascioliosis in
animals and humans.
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